By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    photo of hands with blue veins
    8 Proven Tips on Finding Difficult Veins
    November 12, 2021
    tips for getting over the pandemic blues
    4 Proven Ways to Get Over the Pandemic Blues
    February 22, 2022
    medical industry innovations
    How is CNC Machining Transforming the Medical Industry?
    June 2, 2022
    Latest News
    Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
    May 16, 2025
    Learn how to Renew your Medical Card in West Virginia
    May 16, 2025
    Choosing the Right Supplement Manufacturer for Your Brand
    May 1, 2025
    Engineering Temporary Hospitals for Extreme Weather
    April 24, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Doctors on Google: Manhattan Research Survey 2012
    July 23, 2012
    HealthCare’s Need for Transparency Goes Far Beyond Pricing
    December 10, 2012
    Medicare Payments to Providers Are Carved, Sliced and Chopped by Sequestration
    March 25, 2013
    Latest News
    Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
    May 18, 2025
    The Critical Role of Healthcare in Personal Injury Recovery: A Comprehensive Guide for Victims
    May 14, 2025
    The Backbone of Successful Trials: Clinical Data Management
    April 28, 2025
    Advancing Your Healthcare Career through Education and Specialization
    April 16, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Bioterrorism: Pentagon Goes Back to the Drawing Board
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Public Health > Bioterrorism: Pentagon Goes Back to the Drawing Board
Public Health

Bioterrorism: Pentagon Goes Back to the Drawing Board

GlennLaffel
Last updated: August 23, 2017 1:46 pm
GlennLaffel
Share
4 Min Read
SHARE

The horrifying events of September 11, 2001 and the subsequent weaponized anthrax scare shook-up every American. Officials in charge of homeland defense were particularly shocked. Among other things, it dawned on them that our nation had no good way to defend itself against future bioterrorist attacks.

Soon thereafter, the Pentagon set aside $1 billion to develop treatments for soldiers and civilians who became infected in a bioterrorist attack. The funds went to something called the Transformational Medical Technologies program, which quickly disbursed them to more than 100 universities, drug companies and biotech companies.

The primary goal of the research spawned by these grants was to develop medicines that could neutralize bacteria and viruses that had been specially designed by terrorists to kill people and resist all known therapeutic agents. The infectious agents targeted by the scientists included Ebola, Marburg, Lassa, Sabia, Machupo and Junin.

But now, 5 years after the grants were disbursed, Pentagon officials are pretty much calling the program a bust. Just 2 experimental drugs have shown promise, and they are years away from clinical testing, let alone commercialization.

The major problem, it seems, is technical. It turns out to be easier to increase the lethality of a virus than it is to devise ways to fight it.

“The offensive capabilities outrun the defensive capabilities as the march of biology continues,’’ Richard Danzig, a former Navy secretary and bioterrorism expert said in an interview. “The theory behind [the program] was these same advances should empower the defenses,’’ he explained. “That intuition is worth exploring and investing in, but it is easier to conceive than to execute.’’

A secondary problem should have been anticipated by the Pentagon in advance: for ethical reasons, experimental treatments for nasty germs like these cannot be tested in human clinical trials, yet the FDA requires data from such trials before approving them. The work-around strategy is to test the agents on animals that have been genetically engineered so as to have traits that mimic what is seen in humans, but this process is time-consuming and expensive.

So What Will the Pentagon to Do? Of course the Pentagon cannot walk away from the effort. The threat of bioterrorism remains. So it has set aside an additional $1 billion to develop fast, inexpensive ways to identify (rather than treat) weaponized versions of the germs mentioned above. In all likelihood, many of the same contractors will play a role in the new effort.

Early identification may not sound as sexy as effective treatment, but it can be extraordinarily important. In particular, it allows public health officials or military leaders to institute quarantines, restrict air travel and take related actions in a timelier manner. This lead-time can vastly reduce transmission the infectious agent in the setting of a bioterror attack.

Of course, this strategy doesn’t help folks who have been infected. To this end, the Pentagon holds out hope that byproducts of the new research will eventually help in the development of antidotes.

It’s a lot better than the alternative, which is inaction. Our fingers are crossed for positive results, and we will follow with interest.

TAGGED:bioterrorismpublic health
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Clinical Expertise
Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
Health care
May 18, 2025
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Health
May 15, 2025
Learn how to Renew your Medical Card in West Virginia
Learn how to Renew your Medical Card in West Virginia
Health
May 15, 2025
Dr. Klaus Rentrop Shares Acute Myocardial Infarction heart treatment
Dr. Klaus Rentrop Shares Acute Myocardial Infarction
Cardiology
May 13, 2025

You Might also Like

Why Not A Nurse?

October 18, 2011
Health carePolicy & LawPublic Health

Why are People Reluctant to Claim Compensation for Accidents?

March 25, 2020

Dramatic Early Clinical Trial Success for New Cancer Treatment

March 14, 2016

Obamacare 411

May 4, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?